ASSOCIATION BETWEEN BODY HEIGHT AND DOUBLE J STENT INTRAVESICAL POSITION AND ITS RELATION WITH THE INDONESIAN VERSION OF URETERAL STENT SYMPTOM QUESTIONNAIRE (USSQ)
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aims to determine the relationship between the patient’s body height with the intravesical double J stent position and whether its position is related to the ureteral stent symptom questionnaire (USSQ). Material & Methods: A cohort study with a study population of patients inserted with double J stent size 4.7 Fr and length 26 cm was carried out at the Department of Urology Hasan Sadikin Academic Medical Center from July 2021 to July 2022. We assess the patient’s demographic features and different body heights into two categories, below and above average. Then we evaluate its stent position using a plain abdominal X-ray and the USSQ score. Results: Ninety samples were included in this study; 30 of them had a midline intravesical double J stent position, 30 pieces of contralateral, and 30 samples of ipsilateral. Only body height correlated to the stent’s position (p<0.05). The results of comparative statistical tests or the association of postoperative complications between 7 days and 30 days in the position of the double J stent midline, contralateral and ipsilateral had significant results (p<0.05). Stent with ipsilateral position showed a lower USSQ score. Conclusion: Men and women above the average height have a lower risk for migration stent to the contralateral side and are also associated with lower USSQ scores. Keywords: Double J stent, USSQ score, double J stent position.
##plugins.themes.bootstrap3.article.details##
Double J stent, USSQ score, double J stent position
Leslie, S. W. & Sajjad, H. Double J Placement Methods Comparative Analysis. 2022.
Betschart, P. et al. Reduction of stent- associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial is assessing a customized ‘suture stent’. BJU Int. 2021; 127: 596–605.
Joshi, H. B., Stainthorpe, A., Keeley, F. X., MacDonagh, R. & Timoney, A. G. Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol. 2001; 15: 151–4.
Abt, D. et al. Is intravesical stent position a predictor of associated morbidity? Korean J Urol. 2015; 56: 370–8.
Giannarini, G. et al. Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated Ureteric Stent Symptoms Questionnaire. BJU Int. 2011; 107: 648–54.
Leibovici, D. et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc. 2005; J 7: 491–4.
Tansol, C., Noegroho, B. S., Safriadi, F. & Sani, W. The indonesian linguistic validation of the ureteral stent symptoms questionnaire. Indonesian Journal of Urology. 2019; 26.
Snell RS. Clinical Anatomy by Regions. Lippincott Williams & Wilkins. 2011.
Taylor, W. N. & McDougall, I. T. Minimally invasive ureteral stent retrieval. J Urol. 2002; 168: 2020–3.
Sharma, S. et al. Use of conventional DJ stent and single loop stent with string after ureterorenoscopic lithotripsy: Can we use? Can it be effective? Urol Ann. 2021; 13(4): 362–366.
Maan, Z. et al. Comparison of stent-related symptoms between conventional Double-J stent and a new-generation thermoexpandable segmental metallic stent: a validated-questionnaire-based study. J Endourol. 2010; 24: 589–93.
Joshi, H. B. et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol. 2003; 169: 1060–4.
Inn, F. X. et al. Intravesical stent position as a predictor of quality of life in patients with indwelling ureteral stent. Int Urol Nephrol. 2019; 51: 1949–1953.
Mehra, K., Manikandan, R., Dorairajan, L. N., Sreenivasan Kodakkattil, S. & Kalra, S. Effect of Ureteral Stent Length and Position of Stent Coil in Bladder on Stent- Related Symptoms and Quality of Life of Patients. Cureus. 2020; 12: e11669.
Taguchi, M., Yasuda, K. & Kinoshita, H. Prospective randomized controlled trial comparing a ureteral stent crossing versus not crossing the bladder midline. World J Urol. 2022; 40: 1537–1543.
Fischer, K. M., Louie, M. & Mucksavage, P. Ureteral Stent Discomfort and Its Management. Curr Urol Rep. 2018; 19: 64.
Vallée, M. et al. Epidemiology and risk factors for ureteral stent-associated urinary tract infections in non-transplanted renal patients: a systematic review of the literature. World J Urol. 2021; 39: 3845–3860
Lee, S.-W., Hsiao, P.-J., Chang, C.-H. & Chou, E.-L. Lower urinary tract symptoms associated with Double-J stent. Urol Sci. 2019; 30: 92.
Shen, P. et al. Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi: a systematic review and meta-analysis. J Urol. 2011; 186: 1328–35.